Secondary prevention of CAD Flashcards
antiplatelet therapy after coronary stenting
DAPT for minimum of 6-12 months after BMS or DES placement
DAPT minimum of 4 weeks in select pts after BMS
Continue DAPT in total of 30 months if posible (low bleeding risk)
continue ASA indefinitely
IF planning to do surgery, what are the recommendations for DAPT?
Elective surgery: defer surgery until minimum DAPT duration
Urgent surgery: continue P2Y12 receptor blocker or HOLD For shortest duration possible
Continue aspirin unless high risk of severe surgical bleeding.
POST MI intervention that improves outcomes after MI with improvement in functional status and quality of life and reduction in repeat hospitalization, recurrent MI and all cause mortality
cardiac rehab - all pts with recent MI, CABG, stable angina pectoris, PCI should get this.
after MI and EF<40% need to be started on this?
ACE i, beta blocker
what exercise interventions can be done to reduce cardiac risk?
exercise of any kind reduces risk. Typical recommendations include:
150 min/ week moderate aerobic exercise or 75 minutes of vigorous exercise
strength training 2 times/ week
what diet should patients adopt to lower cardiac risk?
Mediterranean diet
increased fruit, vegetables, whole grains, legumes, nuts, olive oil, poultry and fish
decrease intake of red meat, salt, saturated fats, moderate intake of red wine (optional)
what is the DASH diet?
helps to lower cardiac risk
intake: fruits, vegetables, whole grains, low fat diary and nuts and fish and poultry
decrease intake of red meat, fats, sweets,
Sodium <2.3 g/day or <1.5 lower sodium DASH diet (meant for out of control HTN pts)
what other habits can help decrease cardiac risk?
stop smoking and moderate and alcohol intake?
what is associated with heavy intake of alcohol ?
> 4 drinks per day per man or 2 drinks per day for women?
increased risk for heart failure.
in a diabetic pt with stable angina and CAD and HTN what medication could be added to help lower her risk for future MI or cardiovascular events?
SGLT-2 inhibitor